Eris Lifesciences Limited (ERIS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.068x

Based on the latest financial reports, Eris Lifesciences Limited (ERIS) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.39 Billion ≈ $25.85 Million USD) by net assets (Rs35.03 Billion ≈ $378.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ERIS company net worth for the company's overall valuation and market capitalisation.

Eris Lifesciences Limited - Cash Flow Conversion Efficiency Trend (2012–2026)

This chart illustrates how Eris Lifesciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Eris Lifesciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eris Lifesciences Limited ranked by their cash flow conversion efficiency. Explore Eris Lifesciences Limited cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
IBF Financial Holdings Co Ltd TW:2889	-0.017x
AVI LTD (UNSP.ADR)/5 F:IZ60	N/A
Hefei Metalforming Mach Tool SHG:603011	-0.003x
Neutron Holdings, Inc. Common Stock NASDAQ:LIME	0.105x
Atea ASA OL:ATEA	-0.248x
Pfizer Limited NSE:PFIZER	0.143x
L1 Group Limited AU:L1G	0.071x
Anywhere Real Estate Inc NYSE:HOUS	0.078x

Annual Cash Flow Conversion Efficiency for Eris Lifesciences Limited (2012–2026)

The table below shows the annual cash flow conversion efficiency of Eris Lifesciences Limited from 2012 to 2026. View Eris Lifesciences Limited (ERIS) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs38.96 Billion ≈ $421.30 Million	Rs3.47 Billion ≈ $37.52 Million	0.089x	-72.64%
2025-03-31	Rs32.72 Billion ≈ $353.83 Million	Rs10.65 Billion ≈ $115.18 Million	0.326x	+115.80%
2024-03-31	Rs32.22 Billion ≈ $348.45 Million	Rs4.86 Billion ≈ $52.56 Million	0.151x	+14.82%
2023-03-31	Rs22.21 Billion ≈ $240.16 Million	Rs2.92 Billion ≈ $31.55 Million	0.131x	-33.73%
2022-03-31	Rs19.08 Billion ≈ $206.36 Million	Rs3.78 Billion ≈ $40.91 Million	0.198x	-16.75%
2021-03-31	Rs15.76 Billion ≈ $170.48 Million	Rs3.75 Billion ≈ $40.59 Million	0.238x	+13.85%
2020-03-31	Rs12.96 Billion ≈ $140.19 Million	Rs2.71 Billion ≈ $29.32 Million	0.209x	+9.62%
2019-03-31	Rs11.69 Billion ≈ $126.40 Million	Rs2.23 Billion ≈ $24.12 Million	0.191x	-27.96%
2018-03-31	Rs8.86 Billion ≈ $95.81 Million	Rs2.35 Billion ≈ $25.37 Million	0.265x	-28.46%
2017-03-31	Rs5.40 Billion ≈ $58.39 Million	Rs2.00 Billion ≈ $21.61 Million	0.370x	-8.77%
2016-03-31	Rs3.24 Billion ≈ $35.04 Million	Rs1.31 Billion ≈ $14.22 Million	0.406x	+21.46%
2015-03-31	Rs2.70 Billion ≈ $29.16 Million	Rs900.57 Million ≈ $9.74 Million	0.334x	-32.59%
2014-03-31	Rs1.81 Billion ≈ $19.56 Million	Rs896.24 Million ≈ $9.69 Million	0.496x	+44.48%
2013-03-31	Rs1.11 Billion ≈ $11.99 Million	Rs380.15 Million ≈ $4.11 Million	0.343x	-40.12%
2012-03-31	Rs528.98 Million ≈ $5.72 Million	Rs302.99 Million ≈ $3.28 Million	0.573x	--

About Eris Lifesciences Limited

NSE:ERIS India Drug Manufacturers - Specialty & Generic

Market Cap

$1.98 Billion

Rs183.11 Billion INR

Market Cap Rank

#6254 Global

#282 in India

Share Price

Rs1321.30

Change (1 day)

+0.81%

52-Week Range

Rs1271.00 - Rs1701.30

All Time High

Rs1847.70